Cytoplasmic Expression of EGFP in Dendritic Cells Transfected with In Vitro Transcribed mRNA or Cellular Total RNA Extracted from EGFP Expressing Leukemia Cells

Medical Oncology

Volumn 20, Issue 4, 2003, Pages 335-348

  Takahashi, Masuhiro ^a   Narita, Miwako ^a   Ayres, Flavio ^b   Satoh, Naoko ^b   Abe, Takashi ^b   Yanao, Toshio ^b   Furukawa, Tatsuo ^c   Toba, Ken ^b   Hirohashi, Takeshi ^d   Aizawa, Yoshifusa ^b  

^a NIIGATA UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY GRADUATE SCHOOL OF MEDICAL AND DENTAL SCIENCES   (Japan)

^c NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^d Hirohashi Gynecol and Obstet Clin   (Japan)

Author keywords

Cellular total RNA; Dendritic cells; EGFP; Electroporation; IVT mRNA; RNA transfection

Indexed keywords

CD34 ANTIGEN; COMPLEMENTARY DNA; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GREEN FLUORESCENT PROTEIN; INTERLEUKIN 4; MESSENGER RNA; RNA; STEM CELL FACTOR; TUMOR ANTIGEN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER IMMUNOTHERAPY; CELL STRAIN K 562; CONTROLLED STUDY; CYTOPLASM; DENDRITIC CELL; ELECTRIC FIELD; ELECTROPORATION; FLOW CYTOMETRY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; LEUKEMIA CELL; MIXED LYMPHOCYTE CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RNA TRANSCRIPTION;

DENDRITIC CELLS; ELECTROPORATION; GREEN FLUORESCENT PROTEINS; HUMANS; IMMUNOTHERAPY; LUMINESCENT PROTEINS; RNA, MESSENGER; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 9144256667     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1385/MO:20:4:335     Document Type: Article

References (29)

1. Sullenger BA, Gilboa E. Emerging clinical applications of RNA. Nature 2002;418:252-258.
2. Ashley DM, et al. Bone marrow-generated dendritic cells pulsed with tumor extracts or tumor RNA induce antitumor immunity against central nervous system tumors. J Exp Med 1997;186:1177-1182.
3. Nair SK, et al. Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA. Nat Biotechnol 1998;16:364-369.
4. Heiser A, et al. Human dendritic cells transfected with RNA encoding prostate-specific antigen stimulate prostate-specific CTL responses in vitro. J Immunol 2000;164:5508-5514.
5. Schmitt WE, et al. Cochlovius B. In vitro induction of a bladder cancer-specific T-cell response by mRNA-transfected dendritic cells. J Cancer Res Clin Oncol 2001;127:203-206.
6. Heiser A, et al. Human dendritic cells transfected with renal tumor RNA stimulate polyclonal T-cell responses against antigens expressed by primary and metastatic tumors. Cancer Res 2001;61:3388-3393.
7. Heiser A, et al. Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors. J Clin Invest 2002;109:409-417.
8. Nair SK, et al. Induction of tumor-specific cytotoxic T lymphocytes in cancer patients by autologous tumor RNA-transfected dendritic cells. Ann Surg 2002;235:540-549.
9. Lu D, et al. Optimization of methods to achieve mRNA-mediated transfection of tumor cells in vitro and in vivo employing cationic liposome vectors. Cancer Gene Ther 1994;1:245-252.
10. Boczkowski D, et al. Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J Exp Med 1996;184:465-472.
11. Koido S, et al. Induction of antitumor immunity by vaccination of dendritic cells transfected with MUC1 RNA. J Immunol 2000;165:5713-5719.
12. Weissman D, et al. HIV gag mRNA transfection of dendritic cells (DC) delivers encoded antigen to MHC class I and II molecules, causes DC maturation, and induces a potent human in vitro primary immune response. J Immunol 2000;165:4710-4717.
13. Boczkowski D, et al. Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells. Cancer Res 2000;60:1028-1034.
14. Bacci A, et al. Dendritic cells pulsed with fungal RNA induce protective immunity to Candida albicans in hematopoietic transplantation. J Immunol 2002;168:2904-2913.
15. Su Z, et al. Enhanced induction of telomerase-specific CD4 (+) T cells using dendritic cells transfected with RNA encoding a chimeric gene product. Cancer Res 2002;62:5041-5048.
16. Strobel I, et al. Human dendritic cells transfected with either RNA or DNA encoding influenza matrix protein M1 differ in their ability to stimulate cytotoxic T lymphocytes. Gene Ther 2000;7:2028-2035.
17. Van Tendeloo VF, et al. Highly efficient gene delivery by mRNA electroporation in human hematopoietic cells: superiority to lipofection and passive pulsing of mRNA and to electroporation of plasmid cDNA for tumor antigen loading of dendritic cells. Blood 2001;98:49-56.
18. Saeboe-Larssen S, et al. mRNA-based electrotransfection of human dendritic cells and induction of cytotoxic T lymphocyte responses against the telomerase catalytic subunit (hTERT). J Immunol Methods 2002;259:191-203.
19. Eppler E, et al. Carcinoembryonic antigen (CEA) presentation and specific T cell-priming by human dendritic cells transfected with CEA-mRNA. Eur J Cancer 2002;38:184-193.
20. Kalady MF, et al. Enhanced dendritic cell antigen presentation in RNA-based immunotherapy. J Surg Res 2002;105:17-24.
21. Zheng Z, et al. Generation of dendritic cells from adherent cells of cord blood by culture with GM-CSF, IL-4 and TNF-α. J Hematother & Stem Cell Res 2000;9:445-456.
22. Osman Y, et al. Generation of bcr-abl specific cytotoxic T-lymphocytes by using dendritic cells pulsed with bcr-abl (b3a2) peptide: its applicability for donor leukocyte transfusions in marrow grafted CML patients. Leukemia 1999;13:166-174.
23. Takahashi M, et al. Effects of transfection of P210bcr-abl and bcr-v-abl into the factor-dependent human leukemia cell line HSM-911. Leuk Res 1997;21:1115-1123.
24. Narita M, et al. Leukemia blasts-induced T cell anergy demonstrated by leukemia derived dendritic cells in acute myelogenous leukemia. Exp Hematol 2001;29:709-719.
25. Sun JY, et al. Immunogenicity of a p210 (BCR-ABL) fusion domain candidate DNA vaccine targeted to dendritic cells by a recombinant adeno-associated virus vector in vitro. Cancer Res 2002;62:3175-3183.
26. Nair SK, et al. Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells. Nat Med 2000;6:1011-1017.
27. Heiser A, et al. Induction of polyclonal prostate cancer-specific CTL using dendritic cells transfected with amplified tumor RNA. J Immunol 2001;166:2953-2960.
28. Re F, et al. Green fluorescent protein (GFP) expression in dendritic cells enhances their immunogenicity and elicits GFP-specific cytotoxic T-cell (CTL) responses in humans. Blood 2002;100 (suppl1):676a (Abstract 2663).
29. Osman Y, et al. Generation of antigen specific cytotoxic T lymphocytes by dendritic cells transfected with in vitro transcribed influenza virus matrix protein (M1) mRNA. Cytotherapy 2003;5:161-168.